Abbott Laboratories ABL.DE Stock
Abbott Laboratories Price Chart
Abbott Laboratories ABL.DE Financial and Trading Overview
Abbott Laboratories stock price | 102.82 EUR |
Previous Close | 94.94 EUR |
Open | 95.15 EUR |
Bid | 95.62 EUR x 69000 |
Ask | 96.5 EUR x 78000 |
Day's Range | 95.15 - 96.34 EUR |
52 Week Range | 89.03 - 111.5 EUR |
Volume | 129 EUR |
Avg. Volume | 373 EUR |
Market Cap | 167.75B EUR |
Beta (5Y Monthly) | 0.663028 |
PE Ratio (TTM) | 31.381107 |
EPS (TTM) | 3.04 EUR |
Forward Dividend & Yield | 1.91 (2.02%) |
Ex-Dividend Date | July 13, 2023 |
1y Target Est | N/A |
ABL.DE Valuation Measures
Enterprise Value | 174.43B EUR |
Trailing P/E | 31.381107 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 4.0417304 |
Price/Book (mrq) | 4.526617 |
Enterprise Value/Revenue | 4.203 |
Enterprise Value/EBITDA | 16.27 |
Trading Information
Abbott Laboratories Stock Price History
Beta (5Y Monthly) | 0.663028 |
52-Week Change | -2.44% |
S&P500 52-Week Change | 20.43% |
52 Week High | 111.5 EUR |
52 Week Low | 89.03 EUR |
50-Day Moving Average | 97.31 EUR |
200-Day Moving Average | 100.04 EUR |
ABL.DE Share Statistics
Avg. Volume (3 month) | 373 EUR |
Avg. Daily Volume (10-Days) | 156 EUR |
Shares Outstanding | 1.74B |
Float | 1.73B |
Short Ratio | N/A |
% Held by Insiders | 0.54% |
% Held by Institutions | 76.05% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.96 |
Trailing Annual Dividend Yield | 2.06% |
5 Year Average Dividend Yield | 152.00% |
Payout Ratio | 0.5836 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 13.98% |
Operating Margin (ttm) | 18.00% |
Gross Margin | 55.63% |
EBITDA Margin | 25.83% |
Management Effectiveness
Return on Assets (ttm) | 6.31% |
Return on Equity (ttm) | 15.93% |
Income Statement
Revenue (ttm) | 41.51B EUR |
Revenue Per Share (ttm) | 23.75 EUR |
Quarterly Revenue Growth (yoy) | -18.099% |
Gross Profit (ttm) | 24.58B EUR |
EBITDA | 10.72B EUR |
Net Income Avi to Common (ttm) | 5.78B EUR |
Diluted EPS (ttm) | 3.07 |
Quarterly Earnings Growth (yoy) | -46.10% |
Balance Sheet
Total Cash (mrq) | 9.53B EUR |
Total Cash Per Share (mrq) | 5.48 EUR |
Total Debt (mrq) | 17.03B EUR |
Total Debt/Equity (mrq) | 45.73 EUR |
Current Ratio (mrq) | 1.678 |
Book Value Per Share (mrq) | 21.283 |
Cash Flow Statement
Operating Cash Flow (ttm) | 8.66B EUR |
Levered Free Cash Flow (ttm) | 6.41B EUR |
Profile of Abbott Laboratories
Country | Germany |
State | IL |
City | North Chicago |
Address | 100 Abbott Park Road |
ZIP | 60064-6400 |
Phone | 224 667 6100 |
Website | https://www.abbott.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 115000 |
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Q&A For Abbott Laboratories Stock
What is a current ABL.DE stock price?
Abbott Laboratories ABL.DE stock price today per share is 102.82 EUR.
How to purchase Abbott Laboratories stock?
You can buy ABL.DE shares on the XETRA exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Abbott Laboratories?
The stock symbol or ticker of Abbott Laboratories is ABL.DE.
Which industry does the Abbott Laboratories company belong to?
The Abbott Laboratories industry is Medical Devices.
How many shares does Abbott Laboratories have in circulation?
The max supply of Abbott Laboratories shares is 1.74B.
What is Abbott Laboratories Price to Earnings Ratio (PE Ratio)?
Abbott Laboratories PE Ratio is 33.82237000 now.
What was Abbott Laboratories earnings per share over the trailing 12 months (TTM)?
Abbott Laboratories EPS is 3.04 EUR over the trailing 12 months.
Which sector does the Abbott Laboratories company belong to?
The Abbott Laboratories sector is Healthcare.